A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the long-term safety and efficacy of TAU-284
(Bepotastine besilate) in pediatric patients with perennial allergic rhinitis for 12 weeks
administration.